Coronavirus - Overall
-
@Rapido said in Coronavirus - Overall:
Re: Spain.
The Spanish health ministry has just updated the country’s Covid-19 death toll to 28,313 after leaving the figure frozen at 27,136 for almost two weeks while it checked and analysed the data.
The government had been widely criticised for “pausing” the death figures on 7 June, but had defended the move on the grounds that it needed to “review the information on deaths” and establish the date of death, rather than when the death was reported.
Statistics on infections and deaths are collected by each of Spain’s 17 autonomous regions and then given to the central government in Madrid.
Towards the end of May, the health ministry changed its methods for collecting data on cases and deaths, leading to a sharp drop in daily cases and some days when no deaths were reported – despite regional governments reporting fatalities over the same period.
Spanish Health Minister Salvador Illa appears before the parliamentary Commission for Social and Economic reconstruction at the Lower House in Madrid, Spain. Photograph: MARISCAL/EPA
The government argued that the changes had been needed to help it pin down and isolate new outbreaks rather than focusing on the overall picture.
On Friday, the health minister, Salvador Illa, said there have been 34 small outbreaks involving 982 individual cases in Spain over the past four to six weeks. He added that all of the outbreaks were now under control.
Most of the outbreaks were detected among people who had flouted the lockdown to gather for parties, among people working in slaughterhouses, or among seasonal workers or those returning from working abroad.
The government says it is still working to process and provide figures on the number of people who have died from the coronavirus in Spanish care homes. Deaths in homes for elderly or disabled people are expected to account for a significant proportion of all deaths.
Of the 15,043 people who have died from the virus or with associated symptoms in the Madrid region alone, 5,981 were in residential homes.
Mortality figures from the Carlos III research institute in Madrid show that there were 43,360 “excess deaths” – more fatalities than would normally have been expected – in Spain between 13 March and 22 May.
While 77,362 deaths had been anticipated over the period, there were 120,722 – a 56% increase.
The latest figures from the health ministry suggest that confirmed cases of Covid-19 account for at least 64% of those excess deaths.
Sources said that many of the remaining deaths could be down to the virus, but noted that the figures could also be skewed by the fact that many people had been too scared to go to hospital during the height of the pandemic, and may have died at home from strokes or heart attacks as a result.
Quite interesting that deaths didn't peak for some time after lockdown. Some suggesting that indicates that lockdown itself irrelevant.
-
@Winger said in Coronavirus - Overall:
Some US governors thought it was 'safe' to push COVID-19 positive elderly patients back into nursing homes
So is that what passes for analysis now? The irony of the "fake news" critics pumping out dross like this...
-
@pakman said in Coronavirus - Overall:
@Rapido said in Coronavirus - Overall:
@pakman said in Coronavirus - Overall:
Quite interesting that deaths didn't peak for some time after lockdown. Some suggesting that indicates that lockdown itself irrelevant.
Where are you getting that from?
When you click on graph you can see timing of lockdown.
-
So, looks like peak deaths were 12 to 16 days after start of 'state of alarm'. Which on the graph is marked as lockdown.
What would be expected peak date?
From wiki:
Under the state of alarm, the central government retains all powers and all police are under the control of the Interior Ministry. Many nonessential activities are forbidden, including large gatherings, restaurants, museums and the like. However, citizens are still permitted to travel to work and buy essential items, and religious services are allowed under certain conditions
And -2 to 2 days after 'lockdown' (29th March) Their lockdown was very severe. As in kids stuck inside.
On 28 March, the prime minister ordered all non-essential workers to stay home from 30 March to 9 April to bend the curve and contain the epidemic.
-
@JC said in Coronavirus - Overall:
@Winger said in Coronavirus - Overall:
Some US governors thought it was 'safe' to push COVID-19 positive elderly patients back into nursing homes
So is that what passes for analysis now? The irony of the "fake news" critics pumping out dross like this...
How is this fake please? Genuine question
-
@Rapido said in Coronavirus - Overall:
So, looks like peak deaths were 12 to 16 days after start of 'state of alarm'. Which on the graph is marked as lockdown.
What would be expected peak date?
From wiki:
Under the state of alarm, the central government retains all powers and all police are under the control of the Interior Ministry. Many nonessential activities are forbidden, including large gatherings, restaurants, museums and the like. However, citizens are still permitted to travel to work and buy essential items, and religious services are allowed under certain conditions
And -2 to 2 days after 'lockdown' (29th March) Their lockdown was very severe. As in kids stuck inside.
On 28 March, the prime minister ordered all non-essential workers to stay home from 30 March to 9 April to bend the curve and contain the epidemic.
-
@pakman said in Coronavirus - Overall:
@Rapido said in Coronavirus - Overall:
So, looks like peak deaths were 12 to 16 days after start of 'state of alarm'. Which on the graph is marked as lockdown.
What would be expected peak date?
From wiki:
Under the state of alarm, the central government retains all powers and all police are under the control of the Interior Ministry. Many nonessential activities are forbidden, including large gatherings, restaurants, museums and the like. However, citizens are still permitted to travel to work and buy essential items, and religious services are allowed under certain conditions
And -2 to 2 days after 'lockdown' (29th March) Their lockdown was very severe. As in kids stuck inside.
On 28 March, the prime minister ordered all non-essential workers to stay home from 30 March to 9 April to bend the curve and contain the epidemic.
Oh oh
-
Yawn. All these lockdowns are a waste of time experts. Please explain Brazil, USA etc.
-
@Billy-Tell said in Coronavirus - Overall:
Yawn. All these lockdowns are a waste of time experts. Please explain Brazil, USA etc.
Did anybody say they are a waste of time? It's quite clear that when it comes to limiting the human damage to CV that harsh lockdowns are the only way forwards. It's also quite clear that if you are extremely successful at eradicating the disease from your country with limited loss/spread, then you need to remain firmly closed for a huge amount of time. Basically until there are no cases worldwide, or there is a vaccine. This could be as long as 2 years.
The economic and other fallouts from this border close come with their own catastrophes.
Not saying either side is right or wrong. A month ago, I think I wrote on here how homesick I was due to the handling of the virus and the genuine feeling/mood of the UK whilst reading about NZ coming out / moving forwards..
Now, I'm not so sure that holds true.Although it may just be because we have another clear blue sky 30 degree plus week coming up. The sun does funny things to Poms.
-
@MiketheSnow The analysis takes a single data point (number of deaths in care homes), spins that into a number of avoidable deaths (which is conjecture) then blames someone for the theoretical number.
The handling of the Covid-19 outbreak in the US seems to have been poor at all levels, and in New York worse than most places. Some proper analysis, without the political hits, the inevitable ambulance chasing and the preconceived reasoning would be really helpful. There may be a story here but this isn’t it.
-
-
From his own website:
Dr. Murray is one of the world’s leading authorities on natural medicine. He has published over 30 books featuring natural approaches to health. ..He has personally collected over 65,000 articles from the scientific literature, which provide strong evidence on the effectiveness of diet, vitamins, minerals, herbs, and other natural measures in the maintenance of health and the treatment of disease. It is from this constantly expanding database that Dr. Murray provides the answers on health and healing on DoctorMurray.com...
Unfortunately, many people are not aware of the natural approach that can put them on the road to lifelong health. Dr. Murray has dedicated his life to educating physicians, patients, and the general public on the tremendous healing power of nature.
-
@dogmeat said in Coronavirus - Overall:
From his own website:
Dr. Murray is one of the world’s leading authorities on natural medicine. He has published over 30 books featuring natural approaches to health. ..He has personally collected over 65,000 articles from the scientific literature, which provide strong evidence on the effectiveness of diet, vitamins, minerals, herbs, and other natural measures in the maintenance of health and the treatment of disease. It is from this constantly expanding database that Dr. Murray provides the answers on health and healing on DoctorMurray.com...
Unfortunately, many people are not aware of the natural approach that can put them on the road to lifelong health. Dr. Murray has dedicated his life to educating physicians, patients, and the general public on the tremendous healing power of nature.
Well that's that source goooone then.... Woooooooo!!!
-
COVID-19 drug remdesivir priced at $3650 per patient in developed nations
Gilead Sciences Inc on Monday priced its COVID-19 antiviral remdesivir at US$2340 ($3650) per patient for wealthier nations - and agreed to send nearly all of its supply of the drug to the United States over the next three months.
The price tag is slightly below the range of US$2520 to US$2800 suggested last week by US drug pricing research group the Institute for Clinical and Economic Review (ICER) after British researchers said they found that the cheap, widely available steroid dexamethasone significantly reduced mortality among severely ill COVID-19 patients.
New Zealand's joining the race for a COVID vaccine by backing research both at home and overseas. But if a vaccine is developed, New Zealand will have to join the queue.
Government pledges $37m to help secure COVID-19 vaccine
Africa and Brazil are set to start COVID-19 trials.
Coronavirus vaccine trials start in South Africa and Brazil
Remdesivir is expected to be in high demand as one of the only treatments so far shown to alter the course of COVID-19. After the intravenously administered medicine helped shorten hospital recovery times in a clinical trial, it won emergency use authorisation in the United States and full approval in Japan.
The drug is believed to be most effective in treating patients earlier in the course of disease than dexamethasone, which reduced deaths in patients requiring supportive oxygen and those on a ventilator. Still, remdesivir in its currently formulation, is only being used on patients sick enough to require hospitalization as a five-day treatment course.
The company is developing an inhaled version that could be used outside a hospital setting.
The most important news delivered straight to your inbox
Email Address
View our Terms of Access & Privacy Policy
For US patients with commercial insurance, Gilead said it will charge US$3120 per course, or US$520 per vial. That is a 33 percent increase over the US$390 per vial Gilead said it will charge governments of developed countries and US patients in government healthcare programs.
'Outrageous price for a very modest drug'
In an open letter, Gilead chief executive Daniel O'Day said the price is well below the value it provides given that early hospital discharges could save around US$12,000 per patient in the United States.
Patient advocates have argued that the cost should be lower since remdesivir was developed with financial support from the US government.
US Representative Lloyd Doggett, a Democrat from Texas, said it was "an outrageous price for a very modest drug, which taxpayer funding saved from a scrapheap of failures".
Remdesivir had previously failed as an Ebola treatment and has not shown that it can reduce COVID-19 deaths.
Gilead also said it agreed to continue to send most of its supply of remdesivir to the US Department of Health and Human Services (HHS), with the agency and states set to manage allocation to US hospitals until the end of September.
There are currently more cases of COVID-19 in the United States than in Europe, with several US states hitting new records for numbers of cases.
HHS has been distributing the drug since May and was due to run out after this week. A senior HHS official said the agency expects the drug will soon be a scarce resource, and so it wanted to remain involved in allocating it.
The agency said it secured more than 500,000 remdesivir courses for US hospitals through September. That represents all of Gilead's projected production for July and 90 percent of its production in August and September, in addition to an allocation for clinical trials, HHS said.
Once supplies are less constrained, HHS will stop managing the allocation, Gilead said. The company did not discuss its supply strategy for developed nations outside the United States.
Remdesivir's price has been a topic of intense debate. Experts have said Gilead would need to avoid appearing to take advantage of a health crisis for profits.
Gilead shares were about flat on Monday.
Analysts at Royal Bank of Canada forecast the drug could generate $2.3 billion in revenue 2020, helping offset more than $1 billion in development and distribution costs. They said additional profits could be limited because vaccines and better treatments are on the horizon.
The European Union's healthcare regulator last week recommended conditional approval of the drug when used in the critically ill.
Gilead has linked up with generic drugmakers based in India and Pakistan, including Cipla Ltd and Hetero Labs Ltd, to make and supply remdesivir in 127 developing countries.
Cipla's version is priced at less than 5000 Indian rupees (US$66.24), while Hetero Lab's version is priced at 5400 rupees (US$71.54).